Titration assay for vaccinia based products
Ended Awarded Last action
- Contract number
- HHSN26100008
- Awardee
-
Bioreliance Corporation UEI H3KAG9A26K77
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $0
Award facts
- Contract value 0% obligated
-
- $0.00 Current, with exercised options
- $3,315.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$3,315 | |
| Original award | $3,315 |
Quick answers
Who was awarded contract HHSN26100008?
HHSN26100008 was awarded to Bioreliance Corporation by National Cancer Institute (National Institutes of Health) on February 17, 2015.
How much is contract HHSN26100008 worth?
The government has obligated $0 on HHSN26100008. Its potential value, with all options, is $3,315.
Is contract HHSN26100008 an order under another contract?
Yes. HHSN26100008 is a BPA call under HHSN263199800048997B, a blanket purchase agreement.
Was contract HHSN26100008 competed?
The extent of competition for HHSN26100008 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award